Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges

Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges Bradley J. Monk, Ali Mahdavi Oncologist 2005; 10: 528-538 Author Information and Disclosures Target Audience: Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the immune mechanisms relevant to the control of HPV infection. Describe vaccine strategies for the prevention and therapy of HPV infection and cervical dysplasia and/or cancer. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Aug. 03, 2005 Most Recent Review: Aug. 03, 2005* Most Recent Update: Aug. 03, 2005 Date Credit Expires: Aug. 03, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.